Q32 Bio (QTTB) Cash from Operations Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 20.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.23% |
| Dec 31, 2025 | 38.98% |
| Sep 30, 2025 | 44.64% |
| Jun 30, 2025 | 29.84% |
| Mar 31, 2025 | 25.90% |
| Dec 31, 2024 | 27.85% |
| Sep 30, 2024 | 8.38% |
| Jun 30, 2024 | 2.69% |
| Mar 31, 2024 | 21.27% |
| Dec 31, 2023 | 2.64% |
| Sep 30, 2023 | 36.63% |
| Jun 30, 2023 | 25.94% |
| Mar 31, 2023 | 21.51% |
| Dec 31, 2022 | -1.08% |
| Sep 30, 2022 | 0.73% |
| Jun 30, 2022 | -12.49% |
| Mar 31, 2022 | -19.74% |
| Dec 31, 2021 | -55.59% |
| Sep 30, 2021 | -22.85% |
| Jun 30, 2021 | -35.24% |
| Mar 31, 2021 | -39.25% |
| Dec 31, 2020 | -36.20% |
| Sep 30, 2020 | -74.37% |
| Jun 30, 2020 | -71.02% |
| Mar 31, 2020 | -78.76% |